{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:09:57Z","timestamp":1788930597948,"version":"build-2803163510"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Polymyalgia rheumatica (PMR), a chronic inflammatory disease that affects older people, is characterized by musculoskeletal pain in the shoulder, neck, and pelvic girdle. It can be challenging to discriminate PMR from older age onset rheumatoid arthritis (RA). Systematic investigations of serum proteins have been conducted to identify new biomarkers. However, few proteomic analyses have been conducted for PMR. We analyzed serum protein profiles to identify biomarkers of PMR in the comparison between PMR patients before corticosteroid treatment [PMR Tx(-)] and healthy controls (HCs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Systematic proteome analyses of serum samples from 16 PMR Tx(-) and 18 HCs were performed and candidate proteins were selected with statistical\/cluster and outlier analyses. Validation of the results was performed by the multiplex bead-based immunoassay of 10 candidate proteins in serum from 16 PMR Tx(-), 30 PMR after corticosteroid treatment [PMR Tx(+)], 26 RA, and 16 HCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>C-C motif chemokine ligand (CCL)7, C-X-C motif chemokine ligand (CXCL)9, interleukin (IL)-6, matrix metalloproteinase (MMP)-8, interferon (IFN)-alpha, and MMP-3 levels were increased in PMR Tx(-) compared with HC. Area under the curve values of receiver operating characteristic curves of CXCL9, IL-6, and IL-1 receptor antagonist were 0.94, 0.97, and 0.94, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum biomarker profiles could represent diagnostic biomarkers for PMR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1948036","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:41:10Z","timestamp":1788928870000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum protein biomarkers for polymyalgia rheumatica: a case-control study"],"prefix":"10.3389","volume":"17","author":[{"given":"Hiroshi","family":"Furukawa","sequence":"first","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital","place":["Kiyose, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Hikichi","sequence":"additional","affiliation":[{"name":"Tuning Fork Bio Japan, MITSUI LINK-Lab SHINKIBA 2","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kunieda","sequence":"additional","affiliation":[{"name":"Tuning Fork Bio Japan, MITSUI LINK-Lab SHINKIBA 2","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shomi","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital","place":["Kiyose, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital","place":["Kiyose, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital","place":["Kiyose, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital","place":["Kiyose, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0140-6736(12)60680-1","article-title":"Polymyalgia rheumatica","volume":"381","author":"Kermani","year":"2013","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102670","article-title":"The pathophysiology of polymyalgia rheumatica, small pieces of a big puzzle","volume":"19","author":"Carvajal Alegria","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-007-0595-6","article-title":"Clinical characteristics of polymyalgia rheumatica in Japanese patients: evidence of synovitis and extracapsular inflammatory changes by fat suppression magnetic resonance imaging","volume":"17","author":"Mori","year":"2007","journal-title":"Mod Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/road026","article-title":"Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 2020","volume":"6","author":"Tanaka","year":"2023","journal-title":"Mod Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41598-024-51320-3","article-title":"The contributions of deleterious rare alleles in NLRP12 and inflammasome-related genes to polymyalgia rheumatica","volume":"14","author":"Higuchi","year":"2024","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/art.24793","article-title":"Polymyalgia rheumatica prevalence in a population-based sample","volume":"61","author":"Bernatsky","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2004.06.003","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-1849-3","article-title":"The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan","volume":"32","author":"Okumura","year":"2012","journal-title":"Rheumatol Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.4172\/2161-1149.s6-003","article-title":"Polymyalgia rheumatica and its association with cancer","author":"Pfeifer","year":"2015","journal-title":"Rheumatol (Sunnyvale)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203465","article-title":"Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database","volume":"73","author":"Muller","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11926-020-00919-2","article-title":"Polymyalgia rheumatica: a common disease in seniors","volume":"22","author":"Gazitt","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13075-018-1757-y","article-title":"Comorbidities in polymyalgia rheumatica: a systematic review","volume":"20","author":"Partington","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1136\/rmdopen-2023-003897","article-title":"Human leucocyte antigens and Japanese patients with polymyalgia rheumatica: the protective effect of DRB1*09:01","volume":"10","author":"Nogi","year":"2024","journal-title":"RMD Open"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000694","article-title":"Polymyalgia rheumatica: an autoinflammatory disorder","volume":"4","author":"Floris","year":"2018","journal-title":"RMD Open"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-07209-7","article-title":"Study on the changes and significance of CXCL10 level in serum of isolated polymyalgia rheumatica","volume":"43","author":"Xu","year":"2024","journal-title":"Clin Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-025-07828-8","article-title":"Study on the chemokine CXCL10 in serum for its value in GCA-PMR spectrum disease stratification","volume":"45","author":"Ke","year":"2026","journal-title":"Clin Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14050449","article-title":"Na\u00efve inflammatory proteome profiles of glucocorticoid responsive polymyalgia rheumatica and rheumatic arthritis patients-links to triggers and proteomic manifestations","volume":"14","author":"Stensballe","year":"2024","journal-title":"J Pers Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ard.2025.09.005","article-title":"Understanding the immunopathophysiology of polymyalgia rheumatica: implications for treatment","volume":"85","author":"Choy","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1136\/rmdopen-2024-004488","article-title":"Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica","volume":"10","author":"Ramon","year":"2024","journal-title":"RMD Open"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102684","article-title":"Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica","volume":"123","author":"Graver","year":"2021","journal-title":"J Autoimmun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2021-217822","article-title":"Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis","volume":"77","author":"Wu","year":"2022","journal-title":"Thorax"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117506","article-title":"Identification of novel candidate biomarkers for acute myocardial infarction by the Olink proteomics platform","volume":"548","author":"Liu","year":"2023","journal-title":"Clin Chim Acta"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2023.107331","article-title":"Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes","volume":"217","author":"Keur","year":"2023","journal-title":"Respir Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1017\/s0959259800003257","article-title":"An evaluation of criteria for polymyalgia rheumatica","volume":"38","author":"Bird","year":"1979","journal-title":"Ann Rheum Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/art.34356","article-title":"2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138461","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1021\/pr050300l","article-title":"Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics","volume":"5","author":"Callister","year":"2006","journal-title":"J Proteome Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on variance and bias","volume":"19","author":"Bolstad","year":"2003","journal-title":"Bioinformatics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"026","DOI":"10.1038\/s41598-026-45180-2","article-title":"Protein microarray-based profiling of salivary IgA antibodies against human proteins in COVID-19 patients with depressive symptoms","volume":"23","author":"Hikichi","year":"2026","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1351.029","article-title":"Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis","volume":"1069","author":"Sulli","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.7.766","article-title":"Cytokines and adhesion molecules in patients with polymyalgia rheumatica","volume":"37","author":"Uddhammar","year":"1998","journal-title":"Br J Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.humimm.2008.10.011","article-title":"Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: Association of IL-1RN*2\/2 genotype with polymyalgia rheumatica","volume":"70","author":"Alvarez-Rodriguez","year":"2009","journal-title":"Hum Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"23653","DOI":"10.1038\/s41598-024-71770-z","article-title":"Antifibrotic effect of disulfiram on bleomycin-induced lung fibrosis in mice and its impact on macrophage infiltration","volume":"14","author":"Okabe","year":"2024","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1136\/rmdopen-2022-002612","article-title":"Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study","volume":"8","author":"De La Fuente","year":"2022","journal-title":"RMD Open"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1948036\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:41:19Z","timestamp":1788928879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1948036\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2026.1948036"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1948036","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"article-number":"1948036"}}